Ramos, Sandra, Brenu, Ekua, Broadley, Simon et al. · Asian Pacific journal of allergy and immunology · 2016 · DOI
This study compared immune system cells in people with ME/CFS, people with multiple sclerosis (MS), and healthy people. Researchers found that ME/CFS patients had higher levels of certain regulatory immune cells called Tregs, while MS patients had lower levels of gamma delta T cells. The findings suggest that ME/CFS and MS affect the immune system in different ways, rather than through the same mechanisms.
This study provides evidence that ME/CFS involves specific immune dysregulation distinct from other conditions like MS, which may eventually help clarify the biological basis of ME/CFS. Understanding these immune differences could lead to better diagnostic approaches and targeted treatments specific to ME/CFS rather than applying MS-based interventions.
This cross-sectional study cannot establish causation—it shows associations at a single time point but does not prove these immune changes cause ME/CFS symptoms. The small sample size (24 ME/CFS patients) limits generalizability, and the study does not explain how these cell differences relate to disease severity or patient outcomes. Findings require validation in larger, longitudinal studies.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.